🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of high doses of SPN-812 i...
Status
Completed
Location
Alliance for Wellness dba Alliance for Research
Start Date
2017-11-20
Trial ID
NCT03247556
Treatments Being Tested
Childhood depression warrants treatment research; including pharmacological...
Status
Completed
Location
Ohio State University Medical Center - Harding Hospital
Start Date
2011-09
Trial ID
NCT01341925
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled, multicenter, 5-arm...
Status
Completed
Location
Florida Clinical Research Center, LLC
Start Date
2016-02-01
Trial ID
NCT02633527
Treatments Being Tested
The primary objective of this study was to demonstrate the superiority of l...
Status
Completed
Location
Site Reference ID/Investigator# 45719
Start Date
2009-01
Trial ID
NCT00357994
This study will evaluate acute symptomatic improvements in cognitive perfor...
Status
Terminated
Location
Multiple Locations
Start Date
2009-04-06
Trial ID
NCT00874939
Treatments Being Tested
The purpose of this study is to test the safety, tolerability, and efficacy...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-27
Trial ID
NCT00704405
Treatments Being Tested
This study is designed to evaluate the potential for a pharmacokinetic (PK)...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01157104
Treatments Being Tested
This study will evaluate the efficacy and safety of SPN-812 (Viloxazine ext...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2019-11-20
Trial ID
NCT04016779
This study will evaluate the efficacy and safety of low doses of SPN-812 in...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2017-10-20
Trial ID
NCT03247530
Treatments Being Tested